Fixed-dose combinations (FDCs) for cardiovascular disease (CVD), where medications combine two or more active ingredients into a single pill, can simplify treatment, enhance adherence, and improve outcomes. FDCs streamline medication regimens, improve patient compliance, and potentially reduce healthcare costs.

This panel discussion moderated by Fausto Pinto aims to highlight the benefits of FDCs and seeks to provide insights into optimizing the use of FDCs in CVD management and promoting their integration into clinical practice. It will delve into what’s new in the soon to be published WHF Roadmap on FDCs and how it can inform health systems globally.